Annual CFO:
-$131.50M-$13.52M(-11.46%)Summary
- As of today, TNGX annual cash from operations is -$131.50 million, with the most recent change of -$13.52 million (-11.46%) on December 31, 2024.
- During the last 3 years, TNGX annual cash from operations has fallen by -$71.97 million (-120.91%).
- TNGX annual cash from operations is now -287.66% below its all-time high of $70.07 million, reached on December 31, 2020.
Performance
TNGX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$30.95M+$5.57M(+15.24%)Summary
- As of today, TNGX quarterly cash from operations is -$30.95 million, with the most recent change of +$5.57 million (+15.24%) on September 30, 2025.
- Over the past year, TNGX quarterly cash from operations has increased by +$2.44 million (+7.30%).
- TNGX quarterly cash from operations is now -135.12% below its all-time high of $88.14 million, reached on September 30, 2020.
Performance
TNGX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$145.81M+$2.44M(+1.64%)Summary
- As of today, TNGX TTM cash from operations is -$145.81 million, with the most recent change of +$2.44 million (+1.64%) on September 30, 2025.
- Over the past year, TNGX TTM cash from operations has dropped by -$23.49 million (-19.21%).
- TNGX TTM cash from operations is now -265.44% below its all-time high of $88.14 million, reached on September 30, 2020.
Performance
TNGX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TNGX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -11.5% | +7.3% | -19.2% |
| 3Y3 Years | -120.9% | -57.8% | -49.2% |
| 5Y5 Years | -287.7% | -135.1% | -265.4% |
TNGX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -120.9% | at low | -57.8% | +25.8% | -49.2% | +1.6% |
| 5Y | 5-Year | -287.7% | at low | -135.1% | +25.8% | -265.4% | +1.6% |
| All-Time | All-Time | -287.7% | at low | -135.1% | +25.8% | -265.4% | +1.6% |
TNGX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$30.95M(+15.2%) | -$145.81M(+1.6%) |
| Jun 2025 | - | -$36.52M(+12.4%) | -$148.25M(-9.5%) |
| Mar 2025 | - | -$41.70M(-13.8%) | -$135.34M(-2.9%) |
| Dec 2024 | -$131.50M(-11.5%) | -$36.65M(-9.8%) | -$131.50M(-7.5%) |
| Sep 2024 | - | -$33.39M(-41.4%) | -$122.32M(-1.9%) |
| Jun 2024 | - | -$23.61M(+37.6%) | -$120.07M(+0.7%) |
| Mar 2024 | - | -$37.86M(-37.8%) | -$120.93M(-2.5%) |
| Dec 2023 | -$117.98M | -$27.47M(+11.8%) | -$117.98M(+0.7%) |
| Sep 2023 | - | -$31.14M(-27.2%) | -$118.78M(-10.7%) |
| Jun 2023 | - | -$24.47M(+29.9%) | -$107.26M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$34.91M(-23.5%) | -$114.32M(-4.8%) |
| Dec 2022 | -$109.08M(-83.2%) | -$28.27M(-44.1%) | -$109.08M(-11.6%) |
| Sep 2022 | - | -$19.61M(+37.8%) | -$97.72M(+1.9%) |
| Jun 2022 | - | -$31.54M(-6.3%) | -$99.60M(-31.8%) |
| Mar 2022 | - | -$29.66M(-75.5%) | -$75.58M(-27.0%) |
| Dec 2021 | -$59.53M(-184.9%) | -$16.90M(+21.4%) | -$59.53M(+1.9%) |
| Sep 2021 | - | -$21.49M(-185.9%) | -$60.69M(-224.0%) |
| Jun 2021 | - | -$7.52M(+44.8%) | $48.94M(-13.3%) |
| Mar 2021 | - | -$13.61M(+24.6%) | $56.46M(-19.4%) |
| Dec 2020 | $70.07M | -$18.06M(-120.5%) | $70.07M(-20.5%) |
| Sep 2020 | - | $88.14M | $88.14M |
FAQ
- What is Tango Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Tango Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Tango Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Tango Therapeutics, Inc.?
- What is Tango Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Tango Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of TNGX is -$131.50M
What is the all-time high annual cash from operations for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high annual cash from operations is $70.07M
What is Tango Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, TNGX annual cash from operations has changed by -$13.52M (-11.46%)
What is Tango Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of TNGX is -$30.95M
What is the all-time high quarterly cash from operations for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high quarterly cash from operations is $88.14M
What is Tango Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, TNGX quarterly cash from operations has changed by +$2.44M (+7.30%)
What is Tango Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of TNGX is -$145.81M
What is the all-time high TTM cash from operations for Tango Therapeutics, Inc.?
Tango Therapeutics, Inc. all-time high TTM cash from operations is $88.14M
What is Tango Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, TNGX TTM cash from operations has changed by -$23.49M (-19.21%)